查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2133971

生物催化劑製造市場預測至2034年－按類型、原料、形態、應用、最終用戶和地區分類的全球分析

Biocatalyst Manufacturing Market Forecasts to 2034 - Global Analysis By Type (Enzymes, Whole Cell Catalysts, Immobilized Biocatalysts, Free/Unbound Biocatalysts and Other Biocatalyst Types), Source, Form, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球生物催化劑製造市場規模將達到 12.5 億美元，並在預測期內以 6.6% 的複合年成長率成長，到 2034 年將達到 21 億美元。

生物催化劑是生物分子，主要是酵素和完整細胞，它們能在工業過程中加速化學反應，但自身卻不被消耗。它們透過降低特定生化轉化所需的活化能發揮作用，從而在溫和條件下實現高選擇性和高效率的合成。這些催化劑來自微生物、植物或動物，可取代傳統化學催化劑應用於各種製造領域。它們獨特的性質有助於抑制有害副產物的生成，最大限度地降低能源消耗，並支持多個工業領域的環境永續生產方式。

對永續製造的需求日益成長

隨著全球對永續製造實踐的日益關注，各行業正被迫採用生物催化製程作為傳統化學合成的環保替代方案。日益成長的監管壓力，旨在減少碳足跡和有毒廢棄物，正在加速生物催化技術在醫藥、食品和化學品生產中的應用。酶工程技術的進步進一步推動了這一轉變，提高了催化效率和工業條件下的穩定性。因此，製造商正加大對觸媒技術的投資，以在滿足嚴格環境標準的同時最佳化營運成本。

高昂的生產和精煉成本

生物催化劑的生產、分離和純化成本高昂，是其商業性化應用的主要障礙。開發穩定且高效的酵素通常需要複雜的發酵製程和先進的後處理技術，這進一步推高了整體生產成本。此外，生物催化劑對極端pH值、溫度和有機溶劑非常敏感，這限制了運作在嚴苛工業環境中的使用壽命。這些因素共同阻礙了市場擴張，尤其對於研發預算有限的中小型企業而言更是如此。

在製藥和精細化學品合成領域進行擴張。

在製藥和精細化工領域，掌性中間體和複雜藥物活性成分日益成長的需求為生物催化劑生產商帶來了巨大的發展機會。生物催化合成途徑具有無與倫比的立體選擇性和區域選擇性，能夠在合成高價值化合物的同時最大限度地減少對環境的影響。隨著藥物研發管線的擴展以及監管機構對更環保的合成途徑的青睞，生物催化劑的應用預計將大幅成長。這一趨勢為專注於客製化酵素設計和客製化生物催化解決方案的公司創造了盈利的商機。

與先進化學催化劑的競爭

先進合成化學催化劑的持續創新和發展對生物催化劑生產市場構成重大威脅。傳統化學催化劑即使在嚴苛的工業環境下也往往表現出優異的耐久性，並且在大規模、高產量生產過程中更具成本效益。此外，奈米技術和新型催化材料的快速發展正在提高傳統化學合成方法的效率和選擇性。這種競爭可能會阻礙生物催化劑的市場滲透，尤其是在成本和耐久性是關鍵營運考量的產業。

新型冠狀病毒（COVID-19）的影響：

新冠疫情初期，由於實驗室關閉和物流限制，生物催化劑供應鏈受到衝擊，研發活動也因此延誤。然而，隨後對藥品、疫苗和消毒劑的需求激增，加速了生物催化製程在快速、永續藥物合成中的應用。疫情後，人們對供應鏈韌性和永續生產的關注，加強了對觸媒技術的長期投資，推動了市場強勁復甦，並在多個工業應用領域實現了擴張。

在預測期內，酵素製劑細分市場預計將佔據最大的市場佔有率。

由於酶具有無與倫比的催化效率和在各個工業領域的廣泛應用，預計在預測期內，酶領域將​​佔據最大的市場佔有率。酵素具有卓越的特異性，即使在溫和的條件下也能有效發揮作用，從而顯著降低生產過程中的能耗並最大限度地減少有害廢棄物的產生。隨著永續和經濟高效的生產方法在各行業中日益重要，製藥、食品加工和生質燃料行業對特種酶的需求持續激增，鞏固了酶領域在市場上的主導地位。

預計在預測期內，基因改造生物（GMO）領域將呈現最高的複合年成長率。

在預測期內，受合成生物學和代謝工程快速發展的推動，基因改造生物（GMO）領域預計將呈現最高的成長率。這些技術能夠對微生物菌株進行精確改造，從而生產出高度專業化、穩健的生物催化劑，並針對特定的工業應用進行最佳化。透過基因工程提高酵素的產量、穩定性和活性，顯著提升了製程的經濟性。因此，對生物工程研究投入的增加以及有利的法規結構正在加速全球範圍內基因改造生物催化劑的商業性化應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於該地區成熟的生物技術和製藥產業，這些產業大量運用生物催化製程。該地區受益於大量的研發投入、強力的智慧財產權保護以及政府對綠色化學和永續製造的支持。此外，美國和加拿大的主要產業參與者率先採用先進的酵素技術，進一步鞏固了該地區在全球生物催化製造業的領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體的快速工業化以及製藥和食品加工業的擴張。中國、印度和日本等國家正加大對生物技術基礎設施和永續製造技術的投資，以滿足不斷成長的國內需求和日益嚴格的環境法規。此外，有利的政府政策、不斷成長的外國直接投資以及經濟實惠的原料供應，正在加速生物催化劑在全部區域的應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球生物催化劑製造市場：按類型分類

  • 酵素
  • 全細胞催化劑
  • 固定化生物催化劑
  • 遊離/未結合的生物催化劑
  • 其他類型的生物催化劑

第6章 全球生物催化劑製造市場：依原料分類

  • 微生物來源（細菌、酵母菌、真菌）
  • 植物來源成分
  • 動物性成分
  • 基因改造生物（GMO）
  • 其他生物來源的原料

第7章：全球生物催化劑製造市場：依形式分類

  • 液體配方
  • 粉末和顆粒狀
  • 凝膠和糊狀
  • 固定化固體載體
  • 其他形式

第8章 全球生物催化劑製造市場：依應用領域分類

  • 藥物及藥物合成
  • 食品/飲料加工
  • 生質燃料和可再生能源
  • 精細化學品和特種化學品
  • 個人護理化妝品
  • 其他用途

第9章 全球生物催化劑製造市場：依最終用戶分類

  • 製藥公司
  • 食品和飲料製造商
  • 生質燃料生產商
  • 化工製造商
  • 個人護理品牌
  • 其他最終用戶

第10章 全球生物催化劑製造市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Novonesis（formerly Novozymes A/S）
  • BASF SE
  • DuPont de Nemours, Inc.
  • DSM-Firmenich
  • Codexis, Inc.
  • Amano Enzyme Inc.
  • Asahi Kasei Corporation
  • Evonik Industries AG
  • Kaneka Corporation
  • Biocatalysts Ltd.
  • Prozomix Limited
  • Creative Enzymes
  • Enzyme Development Corporation
  • Biocon Limited
  • Chr. Hansen Holding A/S
  • AB Enzymes GmbH
  • Sekisui Medical Co., Ltd.
  • Nagase ChemteX Corporation
Product Code: SMRC39715

According to Stratistics MRC, the Global Biocatalyst Manufacturing Market is accounted for $1.25 billion in 2026 and is expected to reach $2.10 billion by 2034 growing at a CAGR of 6.6% during the forecast period. Biocatalysts are biological molecules, primarily enzymes or whole cells, that accelerate chemical reactions in industrial processes without being consumed. They function by lowering the activation energy required for specific biochemical transformations, enabling highly selective and efficient synthesis under mild conditions. These catalysts are derived from microbial, plant, or animal sources and are utilized to replace traditional chemical catalysts in various manufacturing applications. Their inherent specificity reduces unwanted byproducts, minimizes energy consumption, and supports environmentally sustainable production methodologies across multiple industrial sectors.

Market Dynamics:

Driver:

Rising Demand for Sustainable Manufacturing

The increasing global emphasis on sustainable manufacturing practices is compelling industries to adopt biocatalytic processes that offer environmentally friendly alternatives to traditional chemical synthesis. Growing regulatory pressure to reduce carbon footprints and minimize toxic waste generation is accelerating the integration of biocatalysts in pharmaceutical, food, and chemical production. This transition is further supported by advancements in enzyme engineering, which enhance catalytic efficiency and stability under industrial conditions. Consequently, manufacturers are increasingly investing in biocatalyst technologies to achieve compliance with stringent environmental standards while optimizing operational costs.

Restraint:

High Production and Purification Costs

The substantial expenses associated with the production, isolation, and purification of biocatalysts represent a significant barrier to their widespread commercial adoption. Developing highly stable and efficient enzymes often requires complex fermentation processes and sophisticated downstream processing techniques, which escalate overall manufacturing costs. Furthermore, the sensitivity of biocatalysts to extreme pH, temperature, and organic solvents limits their operational lifespan in harsh industrial environments. These factors collectively constrain market expansion, particularly for small and medium-sized enterprises with limited research and development budgets.

Opportunity:

Expansion in Pharmaceutical and Fine Chemical Synthesis

The pharmaceutical and fine chemical sectors present substantial growth opportunities for biocatalyst manufacturers due to the increasing demand for chiral intermediates and complex active pharmaceutical ingredients. Biocatalytic routes offer unparalleled stereoselectivity and regioselectivity, enabling the synthesis of high-value compounds with minimal environmental impact. As drug development pipelines expand and regulatory agencies favor greener synthesis pathways, the adoption of biocatalysts is expected to surge. This trend creates lucrative avenues for companies specializing in custom enzyme design and tailored biocatalytic solutions.

Threat:

Competition from Advanced Chemical Catalysts

The continuous innovation and development of advanced synthetic chemical catalysts pose a considerable threat to the biocatalyst manufacturing market. Traditional chemical catalysts often exhibit superior robustness under extreme industrial conditions and can be more cost-effective for large-scale, high-volume production processes. Additionally, the rapid advancement of nanotechnology and novel catalytic materials is enhancing the efficiency and selectivity of conventional chemical synthesis methods. This competitive pressure may hinder the market penetration of biocatalysts, particularly in industries where cost and durability are primary operational considerations.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted biocatalyst supply chains and delayed research and development activities due to laboratory closures and logistical constraints. However, the subsequent surge in demand for pharmaceuticals, vaccines, and sanitization products accelerated the adoption of biocatalytic processes for rapid and sustainable drug synthesis. Post-pandemic, the heightened focus on supply chain resilience and sustainable manufacturing has reinforced long-term investments in biocatalyst technologies, driving robust market recovery and expansion across diverse industrial applications.

The enzymes segment is expected to be the largest during the forecast period

The enzymes segment is expected to account for the largest market share during the forecast period, due to their unparalleled catalytic efficiency and widespread applicability across diverse industrial sectors. Enzymes offer exceptional specificity and operate effectively under mild conditions, which significantly reduces energy consumption and minimizes hazardous waste generation in manufacturing processes. As industries increasingly prioritize sustainable and cost-effective production methods, the demand for specialized enzymes in pharmaceuticals, food processing, and biofuels continues to surge, thereby solidifying their dominant market position.

The genetically modified organisms (GMOs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the genetically modified organisms (GMOs) segment is predicted to witness the highest growth rate, driven by rapid advancements in synthetic biology and metabolic engineering. These technologies enable the precise modification of microbial strains to produce highly specialized and robust biocatalysts tailored for specific industrial applications. The ability to enhance enzyme yield, stability, and activity through genetic manipulation significantly improves process economics. Consequently, increasing investments in bioengineering research and favorable regulatory frameworks are accelerating the commercial adoption of GMO-derived biocatalysts globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the presence of well-established biotechnology and pharmaceutical industries that heavily utilize biocatalytic processes. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive government initiatives promoting green chemistry and sustainable manufacturing. Furthermore, the early adoption of advanced enzyme technologies by key industry players in the United States and Canada reinforces the region's dominant position in the global biocatalyst manufacturing landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid industrialization and expanding pharmaceutical and food processing sectors in emerging economies. Countries such as China, India, and Japan are increasingly investing in biotechnology infrastructure and sustainable manufacturing technologies to meet growing domestic demand and stringent environmental regulations. Additionally, favorable government policies, rising foreign direct investment, and the availability of cost-effective raw materials are collectively driving the accelerated adoption of biocatalysts across the region.

Key players in the market

Some of the key players in Biocatalyst Manufacturing Market include Novonesis (formerly Novozymes A/S), BASF SE, DuPont de Nemours, Inc., DSM-Firmenich, Codexis, Inc., Amano Enzyme Inc., Asahi Kasei Corporation, Evonik Industries AG, Kaneka Corporation, Biocatalysts Ltd., Prozomix Limited, Creative Enzymes, Enzyme Development Corporation, Biocon Limited, Chr. Hansen Holding A/S, AB Enzymes GmbH, Sekisui Medical Co., Ltd., and Nagase ChemteX Corporation.

Key Developments:

In August 2026, Novonesis (formerly Novozymes A/S) launched a next-generation enzyme portfolio optimized for high-temperature industrial processes, achieving a thirty percent improvement in catalytic efficiency while significantly reducing energy consumption requirements for global chemical manufacturing facilities.

In July 2026, BASF SE expanded its biocatalytic production capacity in Europe through a strategic partnership with a leading synthetic biology firm, enabling the scalable manufacturing of novel enzymes for sustainable pharmaceutical intermediate synthesis.

In June 2026, DuPont de Nemours, Inc. secured a major supply agreement to provide customized biocatalysts for a prominent biofuel producer, facilitating the efficient conversion of agricultural residues into advanced renewable transportation fuels globally.

In May 2026, Codexis, Inc. received regulatory approval for its proprietary enzyme engineering platform, accelerating the development of highly specific biocatalysts designed to streamline complex active pharmaceutical ingredient manufacturing processes worldwide.

In April 2026, Evonik Industries AG inaugurated a new state-of-the-art biocatalysis research and development center in Asia, focusing on the discovery and optimization of novel enzymes for the personal care and specialty chemicals markets.

Type Covered:

  • Enzymes
  • Whole Cell Catalysts
  • Immobilized Biocatalysts
  • Free/Unbound Biocatalysts
  • Other Biocatalyst Types

Source Covered:

  • Microbial Sources (Bacteria, Yeast, Fungi)
  • Plant-Derived Sources
  • Animal-Derived Sources
  • Genetically Modified Organisms (GMOs)
  • Other Biological Sources

Form Covered:

  • Liquid Formulations
  • Powdered and Granular Forms
  • Gel and Paste Forms
  • Immobilized Solid Supports
  • Other Forms

Application Covered:

  • Pharmaceutical and Drug Synthesis
  • Food and Beverage Processing
  • Biofuels and Renewable Energy
  • Fine and Specialty Chemicals
  • Personal Care and Cosmetics
  • Other Applications

End User Covered:

  • Pharmaceutical Companies
  • Food and Beverage Manufacturers
  • Biofuel Producers
  • Chemical Manufacturers
  • Personal Care Brands
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biocatalyst Manufacturing Market, By Type

  • 5.1 Enzymes
  • 5.2 Whole Cell Catalysts
  • 5.3 Immobilized Biocatalysts
  • 5.4 Free/Unbound Biocatalysts
  • 5.5 Other Biocatalyst Types

6 Global Biocatalyst Manufacturing Market, By Source

  • 6.1 Microbial Sources (Bacteria, Yeast, Fungi)
  • 6.2 Plant-Derived Sources
  • 6.3 Animal-Derived Sources
  • 6.4 Genetically Modified Organisms (GMOs)
  • 6.5 Other Biological Sources

7 Global Biocatalyst Manufacturing Market, By Form

  • 7.1 Liquid Formulations
  • 7.2 Powdered and Granular Forms
  • 7.3 Gel and Paste Forms
  • 7.4 Immobilized Solid Supports
  • 7.5 Other Forms

8 Global Biocatalyst Manufacturing Market, By Application

  • 8.1 Pharmaceutical and Drug Synthesis
  • 8.2 Food and Beverage Processing
  • 8.3 Biofuels and Renewable Energy
  • 8.4 Fine and Specialty Chemicals
  • 8.5 Personal Care and Cosmetics
  • 8.6 Other Applications

9 Global Biocatalyst Manufacturing Market, By End User

  • 9.1 Pharmaceutical Companies
  • 9.2 Food and Beverage Manufacturers
  • 9.3 Biofuel Producers
  • 9.4 Chemical Manufacturers
  • 9.5 Personal Care Brands
  • 9.6 Other End Users

10 Global Biocatalyst Manufacturing Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Novonesis (formerly Novozymes A/S)
  • 13.2 BASF SE
  • 13.3 DuPont de Nemours, Inc.
  • 13.4 DSM-Firmenich
  • 13.5 Codexis, Inc.
  • 13.6 Amano Enzyme Inc.
  • 13.7 Asahi Kasei Corporation
  • 13.8 Evonik Industries AG
  • 13.9 Kaneka Corporation
  • 13.10 Biocatalysts Ltd.
  • 13.11 Prozomix Limited
  • 13.12 Creative Enzymes
  • 13.13 Enzyme Development Corporation
  • 13.14 Biocon Limited
  • 13.15 Chr. Hansen Holding A/S
  • 13.16 AB Enzymes GmbH
  • 13.17 Sekisui Medical Co., Ltd.
  • 13.18 Nagase ChemteX Corporation

List of Tables

  • Table 1 Global Biocatalyst Manufacturing Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biocatalyst Manufacturing Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Biocatalyst Manufacturing Market Outlook, By Enzymes (2023-2034) ($MN)
  • Table 4 Global Biocatalyst Manufacturing Market Outlook, By Whole Cell Catalysts (2023-2034) ($MN)
  • Table 5 Global Biocatalyst Manufacturing Market Outlook, By Immobilized Biocatalysts (2023-2034) ($MN)
  • Table 6 Global Biocatalyst Manufacturing Market Outlook, By Free/Unbound Biocatalysts (2023-2034) ($MN)
  • Table 7 Global Biocatalyst Manufacturing Market Outlook, By Other Biocatalyst Types (2023-2034) ($MN)
  • Table 8 Global Biocatalyst Manufacturing Market Outlook, By Source (2023-2034) ($MN)
  • Table 9 Global Biocatalyst Manufacturing Market Outlook, By Microbial Sources (Bacteria, Yeast, Fungi) (2023-2034) ($MN)
  • Table 10 Global Biocatalyst Manufacturing Market Outlook, By Plant-Derived Sources (2023-2034) ($MN)
  • Table 11 Global Biocatalyst Manufacturing Market Outlook, By Animal-Derived Sources (2023-2034) ($MN)
  • Table 12 Global Biocatalyst Manufacturing Market Outlook, By Genetically Modified Organisms (GMOs) (2023-2034) ($MN)
  • Table 13 Global Biocatalyst Manufacturing Market Outlook, By Other Biological Sources (2023-2034) ($MN)
  • Table 14 Global Biocatalyst Manufacturing Market Outlook, By Form (2023-2034) ($MN)
  • Table 15 Global Biocatalyst Manufacturing Market Outlook, By Liquid Formulations (2023-2034) ($MN)
  • Table 16 Global Biocatalyst Manufacturing Market Outlook, By Powdered and Granular Forms (2023-2034) ($MN)
  • Table 17 Global Biocatalyst Manufacturing Market Outlook, By Gel and Paste Forms (2023-2034) ($MN)
  • Table 18 Global Biocatalyst Manufacturing Market Outlook, By Immobilized Solid Supports (2023-2034) ($MN)
  • Table 19 Global Biocatalyst Manufacturing Market Outlook, By Other Forms (2023-2034) ($MN)
  • Table 20 Global Biocatalyst Manufacturing Market Outlook, By Application (2023-2034) ($MN)
  • Table 21 Global Biocatalyst Manufacturing Market Outlook, By Pharmaceutical and Drug Synthesis (2023-2034) ($MN)
  • Table 22 Global Biocatalyst Manufacturing Market Outlook, By Food and Beverage Processing (2023-2034) ($MN)
  • Table 23 Global Biocatalyst Manufacturing Market Outlook, By Biofuels and Renewable Energy (2023-2034) ($MN)
  • Table 24 Global Biocatalyst Manufacturing Market Outlook, By Fine and Specialty Chemicals (2023-2034) ($MN)
  • Table 25 Global Biocatalyst Manufacturing Market Outlook, By Personal Care and Cosmetics (2023-2034) ($MN)
  • Table 26 Global Biocatalyst Manufacturing Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 27 Global Biocatalyst Manufacturing Market Outlook, By End User (2023-2034) ($MN)
  • Table 28 Global Biocatalyst Manufacturing Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 29 Global Biocatalyst Manufacturing Market Outlook, By Food and Beverage Manufacturers (2023-2034) ($MN)
  • Table 30 Global Biocatalyst Manufacturing Market Outlook, By Biofuel Producers (2023-2034) ($MN)
  • Table 31 Global Biocatalyst Manufacturing Market Outlook, By Chemical Manufacturers (2023-2034) ($MN)
  • Table 32 Global Biocatalyst Manufacturing Market Outlook, By Personal Care Brands (2023-2034) ($MN)
  • Table 33 Global Biocatalyst Manufacturing Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.